SLT Holdings LLC Invests $3.46 Million in UnitedHealth Group Incorporated (NYSE:UNH)

SLT Holdings LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 6,838 shares of the healthcare conglomerate's stock, valued at approximately $3,459,000. UnitedHealth Group makes up about 3.3% of SLT Holdings LLC's portfolio, making the stock its 8th biggest position.

Other hedge funds have also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $40,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $6.32 during trading hours on Tuesday, reaching $486.54. The company had a trading volume of 4,099,363 shares, compared to its average volume of 4,993,223. The business has a fifty day moving average price of $513.21 and a 200-day moving average price of $552.69. The firm has a market cap of $445.04 billion, a PE ratio of 31.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 earnings per share. UnitedHealth Group's revenue was up 6.8% on a year-over-year basis. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date is Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company's stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.